Transchem Ltd
Fundamental Score
Transchem Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of TRANSCHEM across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Excellent EPS Growth (68.07% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (68.07% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Balanced Promoter Holding (56.45%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
7 factors identified
Below-Average Return on Equity (6.75%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.11%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Profit Decline Concern (-52.78%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Limited Institutional Interest (FII+DII: 0.04%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Transchem Ltd
About TRANSCHEM
Business Overview
Transchem Limited does not have significant operations. Previously, it was engaged in the growing and processing of mushrooms. The company was incorporated in 1976 and is based in Thane, India.
Company Details
Key Leadership
Latest News
TRANSCHEM Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Transchem Ltd (TRANSCHEM)?
As of 08 Feb 2026, 11:53 am IST, Transchem Ltd (TRANSCHEM) is currently trading at ₹164.45. The stock has a market capitalization of ₹122.99 (Cr).
Is TRANSCHEM share price Overvalued or Undervalued?
TRANSCHEM is currently trading at a P/E ratio of 32.45x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Transchem Ltd share price?
Key factors influencing TRANSCHEM's price include its quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Transchem Ltd a good stock for long-term investment?
Transchem Ltd shows a 5-year Profit Growth of 68.07% and an ROE of 6.75%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Transchem Ltd compare with its industry peers?
Transchem Ltd competes with major peers in the Pharmaceuticals. Investors should compare TRANSCHEM's P/E of 32.45x and ROE of 6.75% against the industry averages to determine its competitive standing.
What is the P/E ratio of TRANSCHEM and what does it mean?
TRANSCHEM has a P/E ratio of 32.45x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹32 for every ₹1 of annual earnings.
How is TRANSCHEM performing according to Bull Run's analysis?
TRANSCHEM has a Bull Run fundamental score of 36.1/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does TRANSCHEM belong to?
TRANSCHEM operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Transchem Ltd.
What is Return on Equity (ROE) and why is it important for TRANSCHEM?
TRANSCHEM has an ROE of 6.75%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Transchem Ltd generates profits from shareholders' equity.
How is TRANSCHEM's debt-to-equity ratio and what does it indicate?
TRANSCHEM has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is TRANSCHEM's dividend yield and is it a good dividend stock?
TRANSCHEM offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has TRANSCHEM grown over the past 5 years?
TRANSCHEM has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 68.07%, and EPS Growth 68.07%.
What is the promoter holding in TRANSCHEM and why does it matter?
Promoters hold 56.45% of TRANSCHEM shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is TRANSCHEM's market capitalization category?
TRANSCHEM has a market capitalization of ₹123 crores, placing it in the Small-cap category.
How volatile is TRANSCHEM stock?
TRANSCHEM has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for TRANSCHEM?
TRANSCHEM has a 52-week high of ₹N/A and low of ₹N/A.
What is TRANSCHEM's operating profit margin trend?
TRANSCHEM has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is TRANSCHEM's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of N/A% and YoY Profit Growth of -52.78%.
What is the institutional holding pattern in TRANSCHEM?
TRANSCHEM has FII holding of 0.03% and DII holding of 0.01%. Significant institutional holding often suggests professional confidence in the stock.